Evidence map›Paper›PMID 32678535›Full record

ArticleCellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology2020

Acid Loading Unmasks Glucose Homeostatic Instability in Proximal-Tubule-Targeted Insulin/Insulin-Like-Growth-Factor-1 Receptor Dual Knockout Mice.

Abdullah Aljaylani, Maurice Fluitt, Alexandra Piselli, Blythe D Shepard, Swasti Tiwari, Carolyn M Ecelbarger

Open access · goldAbstract read
In one paragraph

Article in Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Abdullah AljaylaniDivision of Endocrinology and Metabolism, Department of Medicine, Georgetown University, Washington, D.C., USA.
Maurice FluittDivision of Endocrinology and Metabolism, Department of Medicine, Georgetown University, Washington, D.C., USA.
Alexandra PiselliDivision of Endocrinology and Metabolism, Department of Medicine, Georgetown University, Washington, D.C., USA.
Blythe D ShepardSchool of Nursing and Health Studies, Department of Human Science, Georgetown University, Washington, D.C., USA.
Swasti TiwariDepartment of Molecular Medicine & Biotechnology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Utter Pradesh, India.
Carolyn M EcelbargerDivision of Endocrinology and Metabolism, Department of Medicine, Georgetown University, Washington, D.C., USA, ecelbarc@georgetown.edu.
Georgetown University · USSanjay Gandhi Post Graduate Institute of Medical Sciences · IN

Funding

Elucidating the Role of Olfactory Receptor 1393 in Renal Glucose HandlingK01DK106400 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI SHEPARD, BLYTHE D · 2016 to 2021
$657k
American Diabetes Association 1-18-PMF-002Marriott Foundation Cardiovascular FellowshipNIDDK NIH HHS K01 DK106400NIH HHS K01-DK-106400
6 · The paper itself

Abstract

BACKGROUND/

aimsMetabolic syndrome and type 2 diabetes are associated with some degree of acidosis. Acidosis has also been shown to upregulate renal gluconeogenesis. Whether impaired insulin or insulin-like-growth factor 1 receptor (IGF1) signaling alter this relationship is not known. Our aim was to determine the effects of deletion of insulin and IGF1 receptors (Insr and Igf1r) from renal proximal tubule (PT) on the gluconeogenic response to acidosis.

methodsWe developed a mouse model with PT-targeted dual knockout (KO) of the Insr/Igf1r by driving Cre-recombinase with the gamma-glutamyl transferase (gGT) promoter. Male and female mice were maintained as control or acidotic by treatment with NH

resultsAcidosis in both genotypes increased renal expression of phosphoenolpyruvate carboxykinase (PEPCK) and fructose-1-bisphosphatase (FBP1), but not glucose-6-phosphatase catalytic subunit (G6PC), which showed significantly lower expression in the KO regardless of treatment. Several differences between KO and WT suggested a protective role for insulin/IGF1 receptor signaling in maintaining relative euglycemia in the face of acidosis. First, the increase in FBP1 with acid was greater in the KO (significant interactive term). Secondly, proximal-tubule-associated FOXO1 and AKT overall protein levels were suppressed by acid loading in the KO, but not in the WT. Robust intact insulin signaling would be needed to reduce gluconeogenesis in PT. Third, phosphorylated FOXO1 (pS256) levels were markedly reduced by acid loading in the KO PT, but not in the WT. This reduction would support greater gluconeogenesis. Fourth, the sodium-glucose cotransporter (SGLT1) was increased by acid loading in the KO kidney, but not the WT. While this would not necessarily affect gluconeogenesis, it could result in increased circulatory glucose via renal reabsorption. Reduced susceptibility to glucose-homeostatic dysregulation in the WT could potentially relate to the sharp (over 50%) reduction in renal levels of sirtuin-1 (SIRT1), which deacetylates and regulates transcription of a number of genes. This reduction was absent in the KO.

conclusionInsulin resistance of the kidney may increase whole-body glucose instability a major risk factor for morbidity in diabetes. High dietary acid loads provide a dilemma for the kidney, as ammoniagenesis liberates α-ketoglutarate, which is a substrate for gluconeogenesis. We demonstrate an important role for insulin and/or IGF1 receptor signaling in the PT to facilitate this process and reduce excursions in blood glucose. Thus, medications and lifestyle changes that improve renal insulin sensitivity may also provide added benefit in type 2 diabetes especially when coupled with metabolic acidosis.

Indexed as

Acidosis, Renal TubularAmmonium ChlorideAnimalsDiabetes Mellitus, Type 2FemaleForkhead Box Protein O1Fructose-BisphosphataseGluconeogenesisGlucoseGlucose-6-PhosphataseInsulinInsulin ResistanceKidney Tubules, ProximalMaleMiceMice, KnockoutAmmonium ChlorideForkhead Box Protein O1Foxo1 protein, mouseFructose-BisphosphataseGlucoseGlucose-6-PhosphataseInsulinPhosphoenolpyruvate Carboxykinase (ATP)Proto-Oncogene Proteins c-aktReceptor, IGF Type 1Receptor, InsulinSirt1 protein, mouseSirtuin 1Slc5a1 protein, mouseSodium-Glucose Transporter 1Gluconeogenesis; Type 2 diabetes; Metabolic acidosis; Sirtuin-1; FOXO-1

Identifiers

PMID32678535
PMCPMC7414422
OpenAlexW3043505463

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.